WHO study says remdesivir did not reduce mortality in Covid-19 patients

> Earlier this month, Gilead said remdesivir cut COVID-19 recovery time by five days compared to patients on placebo in a 1,062-patient study.

So yeah, it may or may not reduce mortality but still reduces recovery time.